| P50 | author | Yilun Ma | Q87323085 |
| P2093 | author name string | Richard A Cerione | |
| | Marc A Antonyak | |
| | Jingwen Zhang | |
| | Garima Singh | |
| P2860 | cites work | Transglutaminase 2 undergoes a large conformational change upon activation | Q21092747 |
| | Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing | Q24537302 |
| | Global rigid body modeling of macromolecular complexes against small-angle scattering data | Q24538734 |
| | Transglutaminase is a tumor cell and cancer stem cell survival factor | Q26799862 |
| | Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity | Q27638096 |
| | The molecular basis for the regulation of the cap-binding complex by the importins | Q27656958 |
| | Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease | Q28118540 |
| | Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease | Q28145899 |
| | Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function | Q28578829 |
| | c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor | Q29618661 |
| | CRYSOL– a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates | Q29642130 |
| | The v-Src SH3 Domain Binds Phosphatidylinositol 3'-Kinase | Q30194840 |
| | Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells | Q30499127 |
| | EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation | Q33667547 |
| | Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention | Q34927039 |
| | Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells | Q35065126 |
| | Two isoforms of tissue transglutaminase mediate opposing cellular fates | Q35157424 |
| | Transglutaminase 2: a molecular Swiss army knife | Q35693361 |
| | The importance of Src signaling in sarcoma | Q35802929 |
| | Tissue transglutaminase in normal and abnormal wound healing: review article | Q35854245 |
| | Transglutaminase 2 inhibitors and their therapeutic role in disease states | Q35989247 |
| | Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes | Q36233145 |
| | Tissue transglutaminase (TG2)--a wound response enzyme. | Q36251098 |
| | Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei | Q36395820 |
| | Calcium and cell death: the mitochondrial connection. | Q37056461 |
| | A mechanism for the upregulation of EGF receptor levels in glioblastomas | Q37091283 |
| | Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion | Q37258496 |
| | Transglutaminase activation in neurodegenerative diseases. | Q37352964 |
| | Potential of transglutaminase 2 as a therapeutic target. | Q37776508 |
| | TGM2 and implications for human disease: role of alternative splicing | Q38070504 |
| | Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway | Q38170894 |
| | Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer | Q38311664 |
| | A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival | Q38608634 |
| | GTP-binding-defective forms of tissue transglutaminase trigger cell death | Q40041960 |
| | Transglutaminases | Q40082696 |
| | Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation | Q40208016 |
| | Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis | Q40214283 |
| | Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells | Q40532129 |
| | Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro | Q41634983 |
| | Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization | Q42403952 |
| | Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration | Q43819036 |
| | Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord | Q44028734 |
| | Tissue transglutaminase is increased in Huntington's disease brain | Q45299289 |
| | Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. | Q48372615 |
| | Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. | Q54636907 |
| | Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. | Q54651465 |
| | Automated matching of high- and low-resolution structural models | Q56444545 |
| | Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation | Q69875572 |
| | The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor | Q78069495 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9119-9132 | |
| P577 | publication date | 2016-02-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability | |
| P478 | volume | 291 | |